5CT-20727-17748
1 vaccination
1 coded response
7 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Pfizer-BioNTech
- 2021-01-05
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-13
Call successfulDoes not wish to fill out VAERS report
-
2021-01-19
Survey response — day 14, dose 1MedDRA: Serum sickness — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Serum sicknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-02-19
- 2022-01-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-06 | Successful 2021-01-13 |
Does not wish to fill out VAERS report |
| 2021-01-19 | Unsuccessful |
Free text
Release 2 — day 14, dose 1
Symptoms: Serum sickness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Serum sickness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release